Literature DB >> 32454707

Quantitative Structure-Activity Relationship Analysis of Selective Rho Kinase Inhibitors as Neuro-regenerator Agents.

Seema Kesar1, Sarvesh K Paliwal1, Pooja Mishra1, Monika Chauhan1.   

Abstract

OBJECTIVES: To understand the role of Rho (serine/threonine) kinases in the treatment of neurological segments, attempts have been made to find potent inhibitors of Rho enzyme by a 2D quantitative structure-activity relationship (QSAR) model.
MATERIALS AND METHODS: QSAR studies were executed on urea-based scaffolds from aniline and benzylamine analogues, which were aligned for generation of a chemometric-based model. Multivariate statistical approaches were applied including linear and nonlinear analysis such as multiple linear regression, partial least square and artificial neural network for the generation of model, and also an application of (in silico) absorption, distribution, metabolism, excretion studies was performed to ascertain the novelty and drug-like properties of the intended molecules.
RESULTS: Ligand based analysis was implemented and showed excellent statistical relevance such as S value=0.38, F value=48.41, r=0.95, r²=0.91, and r²cv=0.86. Five illuminating variables, i.e., vesicle-associated membrane protein (VAMP) polarization YY component (whole molecule), VAMP dipole Y component (whole molecule), VAMP dipole Z component (whole molecule), Kier ChiV6 path index (whole molecule), and moment of inertia 2 size (whole molecule), were found and they have a profound influence on the potency of the compounds.
CONCLUSION: The values of standard statistical parameters reveal the predictive power and robustness of this model and also provide valuable insight into the significance of five descriptors. The acquired physicochemical properties (electronic, topological, and steric) show the important structural features required for activity against Rho kinase. After performing Lipinski's rule of five on urea-based derivatives no molecule was violating the rule. Therefore, these features can be effectively employed for the modeling and screening of active neurological agents as novel Rho kinase inhibitors. ©Copyright 2019 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  Lipinski’s rule of five; Quantitative structure–activity relationship; chemometric analysis

Year:  2019        PMID: 32454707      PMCID: PMC7227969          DOI: 10.4274/tjps.galenos.2018.70288

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  11 in total

Review 1.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

Review 2.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

3.  Modeling blood-brain barrier partitioning using the electrotopological state.

Authors:  Kimberly Rose; Lowell H Hall; Lemont B Kier
Journal:  J Chem Inf Comput Sci       Date:  2002 May-Jun

Review 4.  Rho and Rac take center stage.

Authors:  Keith Burridge; Krister Wennerberg
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 5.  Rho GTPases and signaling networks.

Authors:  L Van Aelst; C D'Souza-Schorey
Journal:  Genes Dev       Date:  1997-09-15       Impact factor: 11.361

Review 6.  GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors.

Authors:  Kent L Rossman; Channing J Der; John Sondek
Journal:  Nat Rev Mol Cell Biol       Date:  2005-02       Impact factor: 94.444

7.  2,5-Diaminopyrimidines and 3,5-disubstituted azapurines as inhibitors of glycogen synthase kinase-3 (GSK-3).

Authors:  Christopher Lum; Jeff Kahl; Linda Kessler; Jeff Kucharski; Jan Lundström; Stephen Miller; Hiroshi Nakanishi; Yazhong Pei; Kent Pryor; Edward Roberts; Lubomir Sebo; Robert Sullivan; Jan Urban; Zhijun Wang
Journal:  Bioorg Med Chem Lett       Date:  2008-05-06       Impact factor: 2.823

8.  2D-QSAR model development and analysis on variant groups of anti-tuberculosis drugs.

Authors:  Neeraja Dwivedi; Bhartendu Nath Mishra; Vishwa Mohan Katoch
Journal:  Bioinformation       Date:  2011-09-06

Review 9.  Axon growth inhibition by RhoA/ROCK in the central nervous system.

Authors:  Yuki Fujita; Toshihide Yamashita
Journal:  Front Neurosci       Date:  2014-10-22       Impact factor: 4.677

Review 10.  Effect and reporting bias of RhoA/ROCK-blockade intervention on locomotor recovery after spinal cord injury: a systematic review and meta-analysis.

Authors:  Ralf Watzlawick; Emily S Sena; Ulrich Dirnagl; Benedikt Brommer; Marcel A Kopp; Malcolm R Macleod; David W Howells; Jan M Schwab
Journal:  JAMA Neurol       Date:  2014-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.